Latest Ratios: P/E Ratio -9.8x · EV/EBITDA N/A · ROE -5.4%. (2012–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $136M | $259M | $172M | $107M | $365M | $684M | $218M | $593M | — | — | — |
| Enterprise Value | $123M | $240M | $70M | $77M | $300M | $634M | $297M | $595M | — | — | — |
| P/E Ratio → | -9.79 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 1.04 | 1.39 | 1.08 | 0.72 | 2.50 | 8.64 | 2.51 | 7.38 | — | — | — |
| P/B Ratio | 0.50 | 0.74 | 0.56 | 0.40 | 0.72 | 1.43 | 0.73 | 1.81 | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | 44.55 | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.29 | 0.44 | 0.52 | 2.06 | 8.01 | 3.42 | 7.40 | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | 41.37 | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | 156.95 | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.7% | 3.7% | 29.7% | 23.5% | 21.7% | -35.9% | -65.1% | 60.3% | -215.4% | -61.2% | 86.7% |
| Operating Margin | -34.1% | -34.1% | -22.3% | -162.7% | -29.6% | -116.0% | -167.6% | 6.8% | 293.0% | -206.0% | 20.3% |
| Net Profit Margin | -9.6% | -9.6% | -28.4% | -153.8% | -9.8% | -165.1% | -156.9% | -11.9% | 165.0% | -202.1% | 13.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -5.4% | -5.4% | -15.7% | -58.9% | -2.9% | -33.5% | -43.5% | -3.7% | 15.3% | -17.1% | 3.2% |
| ROA | -3.7% | -3.7% | -12.9% | -52.4% | -2.5% | -26.9% | -32.2% | -2.6% | 10.4% | -14.8% | 2.5% |
| ROIC | -17.8% | -17.8% | -12.0% | -53.2% | -7.4% | -17.0% | -30.8% | 1.5% | 17.4% | -13.2% | 3.5% |
| ROCE | -16.0% | -16.0% | -11.3% | -60.8% | -8.2% | -20.0% | -37.6% | 1.6% | 19.3% | -16.1% | 3.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.35 | 0.15 | 0.54 | 0.04 | 0.17 |
| Debt / EBITDA | — | — | — | — | — | — | — | 3.45 | 2.48 | — | 3.69 |
| Net Debt / Equity | — | -0.06 | -0.33 | -0.11 | -0.13 | -0.10 | 0.26 | 0.01 | 0.24 | 0.02 | -0.05 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | 0.14 | 1.10 | — | -1.16 |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | -175.60 | -32.50 | -43.16 | -23.41 | 0.39 | 3.75 | -39.96 | 2.94 |
Net cash position: cash ($28M) exceeds total debt ($9M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.26 | 2.26 | 4.92 | 6.95 | 4.01 | 9.92 | 5.85 | 4.47 | 18.06 | 6.72 | 16.62 |
| Quick Ratio | 1.28 | 1.28 | 3.37 | 3.34 | 2.77 | 8.06 | 3.39 | 1.88 | 12.30 | 5.91 | 14.04 |
| Cash Ratio | 0.23 | 0.23 | 2.02 | 1.51 | 1.79 | 7.00 | 2.57 | 1.09 | 11.56 | 5.11 | 13.34 |
| Asset Turnover | — | 0.33 | 0.39 | 0.50 | 0.25 | 0.14 | 0.21 | 0.19 | 0.04 | 0.06 | 0.11 |
| Inventory Turnover | 1.45 | 1.45 | 1.36 | 1.41 | 1.67 | 2.20 | 2.00 | 0.28 | -0.60 | 1.61 | 0.13 |
| Days Sales Outstanding | — | 127.21 | 84.84 | 67.17 | 116.08 | 96.81 | 71.39 | 52.80 | 23.29 | 68.20 | 93.03 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $128M | $95M | $81M | $85M | $64M | $43M | $35M | $32M | $24M | $15M |
Excise tax margin compression
According to recent market data, OGI trades at a price-to-book ratio of 0.53, which, when compared to the broader sector, suggests that investors are heavily discounting the company's asset base due to persistent operational losses and the ongoing challenges of the Canadian recreational cannabis market.
The current forward P/E of 12.00 appears to imply an expectation of future earnings recovery that may be overly optimistic given the historical volatility in net margins. Investors should monitor whether this valuation reflects a genuine turnaround potential or simply a low-bar expectation for a company struggling to find a path to consistent profitability.
Based on reported financial statements, the company's ROIC has trended into negative territory, reaching -5.5% in 2026Q2, which indicates that the capital invested in the Moncton facility is currently failing to generate returns that exceed the cost of maintaining such a high-fixed-cost indoor cultivation environment.
The inability to sustain positive returns on invested capital suggests that the current business model is struggling to convert its high-precision infrastructure into a competitive advantage that translates to shareholder value. This trend warrants further investigation into whether the company can optimize its yield-per-square-foot enough to overcome the structural drag of excise taxes.
As reported in recent filings, the cash conversion cycle has expanded to 221 days in 2026Q2, a significant increase from previous periods, which suggests that the company is facing mounting difficulties in efficiently turning inventory into cash within the highly competitive and price-sensitive Canadian recreational landscape.
The elevated days inventory outstanding of 244 days highlights a potential mismatch between production volume and market demand, which may lead to further inventory write-downs. This inefficiency appears to be a primary driver of the company's persistent cash burn, as capital remains trapped in unsold product rather than being recycled into growth initiatives.
Based on the company's reported figures, the current ratio of 2.82 in 2026Q2 provides a superficial appearance of stability, yet this liquidity is increasingly pressured by the persistent negative operating cash flows that have characterized the firm's performance over the last ten quarters of operations.
While the balance sheet remains relatively clean of debt, the reliance on existing cash reserves to fund ongoing operations is not a sustainable long-term strategy. Investors should monitor the quick ratio, which at 1.30, suggests that a significant portion of current assets is tied up in inventory that may be subject to future impairment.
As indicated by institutional research trends, the price-to-sales ratio is frequently misapplied to OGI, as it fails to account for the massive excise tax burden that artificially inflates gross revenue figures and obscures the company's actual economic footprint in the Canadian recreational cannabis market.
Analysts should instead focus on contribution margin or adjusted gross margin to better understand the true earning power of the business. Relying on P/S ratios in this context may lead to an overestimation of the company's scale and a misunderstanding of the underlying profitability challenges inherent in the current regulatory environment.
Includes 30+ ratios · 14 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying OGI stock.
Organigram Global Inc.'s current P/E ratio is -9.8x. This places it at the 50th percentile of its historical range.
Organigram Global Inc.'s return on equity (ROE) is -5.4%. The historical average is -35.3%.
Based on historical data, Organigram Global Inc. is trading at a P/E of -9.8x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Organigram Global Inc. has 3.7% gross margin and -34.1% operating margin.